Feng Chen et al.
International journal of clinical and experimental medicine, 8(6), 9820-9824 (2015-08-27)
Tumour markers are used extensively for the management of lung cancer, including diagnosis, evaluating effectiveness of treatments, monitoring recurrence after therapy and for predicting prognosis. However, there exists a knowledge gap regarding potential quantitative correlations between tumour marker levels and